Novartis AG ( NVS) - Stock Earnings
NVS Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| July 21, 2026 BeforeMarket | — / — | — | — / — | — |
NVS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 3.9 billion USD | 14.4 billion USD |
| 2025Q4 | 2.4 billion USD | 13.3 billion USD |
| 2026Q1 | 3.2 billion USD | 13.5 billion USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
NVS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 14.9 billion USD | 46.7 billion USD |
| 2024 | 11.9 billion USD | 51.7 billion USD |
| 2025 | 14.1 billion USD | 54.8 billion USD |
| 2026 Est. | — | — |
NVS
List: Challengers
Price: $153.87
Dividend Yield: 2.96%
Forward Dividend Yield: 3.10%
Payout Ratio: 77.24%
Dividend Per Share: 4.77 USD
Earnings Per Share: 6.98 USD
P/E Ratio: 21.00
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: Switzerland
Volume: 1.7 million
Ebitda: 2.5 billionMarket Capitalization: 305.1 billion
Average Dividend Frequency: 1
Years Paying Dividends: 30
DGR3: 6.30%
DGR5: 5.29%
DGR10: 4.91%
DGR20: 8.93%